As health systems prepare for new interoperability and price transparency regs, Deloitte describes steps they can take to make that work a cornerstone of a broader competitive strategy around consumer experience and cost.
Although the EHR market has made notable changes for the better, there's still ample opportunity for vendors and providers alike to work toward more robust data exchange, a new report shows.
As would-be vaccine recipients scramble for appointment time slots, in too many cases "the technology is just being used wrong," says one exec.
From this month hospitals can apply for government funding under the Hospital Future Act.
The strategy includes a proposed executive order that will direct federal agencies to ramp up collection, sharing and analysis of data to "support an equitable COVID-19 response and recovery."
Vaccines by six developers – Sinopharm, Sinovac, Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, and Sputnik V (Gamaleya Research Institute) – are the ones doing the rounds in the region. Here’s what’s known about them.
There are four main types of vaccines currently approved, in approval or being considered in the MENA region in its fight against COVID-19. We bring you a summary of just what they are, how they differ, along with the advantages and disadvantages of each type.
NHSX develops national imaging database to identify patterns and variations of COVID-19 in UK patients..
While the pandemic has accelerated the adoption of digital tools, it’s an important time to reassess them for long-term success.
Accolade intends to strengthen its ability to provide users with second opinions, using 2nd.MD's provider network.